Viewpoint Capital Management LLC Acquires 1,280 Shares of The Clorox Company (NYSE:CLX)

Viewpoint Capital Management LLC boosted its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 15.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,642 shares of the company’s stock after purchasing an additional 1,280 shares during the period. Viewpoint Capital Management LLC’s holdings in Clorox were worth $1,566,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Brooklyn Investment Group increased its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the 3rd quarter worth about $27,000. Continuum Advisory LLC grew its holdings in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the period. Carolina Wealth Advisors LLC acquired a new position in Clorox during the third quarter valued at approximately $48,000. Finally, Friedenthal Financial acquired a new position in Clorox during the third quarter valued at approximately $49,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

CLX opened at $148.47 on Wednesday. The business has a 50 day moving average of $160.68 and a 200-day moving average of $159.16. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market cap of $18.38 billion, a price-to-earnings ratio of 40.56, a PEG ratio of 2.52 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business posted $2.16 earnings per share. On average, equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.29%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research analyst reports. Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Barclays upped their price target on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Finally, Wells Fargo & Company increased their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $158.21.

Read Our Latest Stock Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.